Accessibility Menu
DocMorris Ag logo

DocMorris Ag(OTC) ZRSEF

Market Cap$364.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-94%
5 Year-96%
1 Year-11%
1 Month+0%
$7.45
+0.00%
+0.00Today
DocMorris Ag last closing stock price
MetricPriceDate
Last closeUSD 7.452026-04-02
DocMorris Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 7.452025-12-26
1 month+0%USD 7.452025-12-26
3 month+0%USD 7.452025-12-26
Year to date+0%USD 7.452025-12-26
1 year-10.92%USD 8.372025-03-13
3 year-72.93%USD 27.532023-03-24
5 year-96.09%USD 190.872021-03-22
Since inception-94.3%USD 130.672018-09-28

DocMorris Ag Financials at a Glance

Market Cap

$364.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CHF 2.14B

Net Income (TTM)

-CHF 231.72M

EPS (TTM)

$0.00

P/E Ratio

-1.61

Dividend

$0.00

Beta (Volatility)

0.04 (Low)

Price

$7.45

Volume

10

Open

$7.45

Previous Close

$7.45

Daily Range

$7.45 - $7.45

52-Week Range

$7.45 - $10.91

Estimated Earnings Date

Aug 19, 2026

ZRSEF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About DocMorris Ag

DocMorris AG, headquartered in Frauenfeld, Switzerland, operates a dual business model that includes e-commerce pharmacies and a wholesale distribution network for medical and pharmaceutical goods. Established in 1993, the company serves both domestic and international markets, offering a diverse range of consumer health and personal care products.

Products and Services
  • E-commerce pharmacy services for consumers
  • Wholesale distribution of medical and pharmaceutical goods
  • Medication management and personal care items
Growth Outlook
  • Revenue increased to CHF 583.57 million in Q4 2025
  • Operating income improved to CHF 71.50 million in Q2 2025
  • Strong market presence with multiple brands like Zur Rose and TeleClinic
Financial Highlights
  • Net income of CHF -72.91 million in Q4 2025
  • Current ratio stands at 2.19, indicating strong liquidity
  • Price-to-sales ratio of 0.47 suggests potential undervaluation
DocMorris AG has established itself as a significant player in the healthcare distribution sector, leveraging its e-commerce capabilities to reach a broad customer base. The company's recent financial performance shows a notable increase in revenue, reflecting its ability to adapt and grow in a competitive market. Despite facing challenges, such as a negative net income, the liquidity position remains robust, providing a cushion for future investments and operational needs. The diverse product offerings and strong brand portfolio position DocMorris AG favorably for continued growth in the evolving healthcare landscape.
AI Generated • Jul 17, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

Employees

1,418

CEO

Walter Hess

Website

corporate.docmorris.com

Headquarters

Frauenfeld, TH 8500, CH

ZRSEF Financials

Key Financial Metrics (TTM)

Gross Margin

9.40%

Operating Margin

-7.50%

Net Income Margin

-11.95%

Return on Equity

-30.22%

Return on Capital

-12.08%

Return on Assets

-16.28%

Earnings Yield

-62.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$364.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

48.89M

Volume

10

Avg. Volume

0

Financials (TTM)

Gross Profit

CHF 322.29M

Operating Income

-CHF 188.55M

EBITDA

-CHF 77.05M

Operating Cash Flow

-CHF 114.90M

Capital Expenditure

-CHF 30.38M

Free Cash Flow

-CHF 145.28M

Cash & ST Invst.

CHF 149.99M

Total Debt

CHF 288.78M

DocMorris Ag Performance Analysis

DocMorris Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CHF 974,770,185-48.4%
20232023-12-31CHF 1,078,796,09510.7%
20242024-12-31CHF 1,154,856,8817.1%
20252025-12-31CHF 1,353,971,86117.2%
DocMorris Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-2.0%
Q42024-12-314.9%
Q22025-06-304.0%
Q42025-12-317.8%
DocMorris Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CHF -8.15-35.4%
20232023-12-31CHF -5.33-34.5%
20242024-12-31CHF -4.61-13.6%
20252025-12-31CHF -4.18-9.4%
DocMorris Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3036.1%
Q42024-12-31-56.2%
Q22025-06-3058.1%
Q42025-12-3176.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CHF 583.57M

+15.2%

Gross Profit

-CHF 15.23M

-149.4%

Gross Margin

-2.61%

N/A

Market Cap

$364.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$256.99K

N/A

Employees

1,418

N/A

Net Income

-CHF 72.91M

-22.9%

EBITDA

-CHF 8.74M

-6.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CHF 149.99M

-0.7%

Total Debt

CHF 288.78M

-12.7%

Accounts Receivable

CHF 82.32M

+48.6%

Inventory

CHF 48.63M

-6.1%

Long Term Debt

CHF 262.32M

+11.0%

Short Term Debt

CHF 26.45M

-72.0%

Return on Assets

-16.28%

N/A

Return on Invested Capital

-12.20%

N/A

Free Cash Flow

-CHF 33.31M

+52.4%

Operating Cash Flow

-CHF 32.65M

+36.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SHPPFRedcare Pharmacy N.V.
$64.80+0.00%
ONTTFOxford Nanopore Technologies plc
$1.54+4.05%
SAEYYRedcare Pharmacy N.V.
$7.55+0.00%
DRWKFDrägerwerk AG & Co. KGaA
$100.47+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About ZRSEF

What is the current price of DocMorris Ag?

DocMorris Ag is trading at $7.45 per share.

What is the 52-week range for DocMorris Ag?

Over the past 52 weeks, DocMorris Ag has traded between $7.45 and $10.91.

How much debt does DocMorris Ag have?

As of the most recent reporting period, DocMorris Ag reported total debt of CHF 390.14M.

How much cash does DocMorris Ag have on hand?

DocMorris Ag reported CHF 188.80M in cash and cash equivalents in its most recent financial results.

What is DocMorris Ag’s dividend yield?

DocMorris Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services